Cargando…
MR-guided radiotherapy in rectal cancer: First clinical experience of an innovative technology
• This study represents one of the first reports of online MRgRT. • Integrated Low-field MR provides better anatomical visualization than CBCT or MVCT. • Better visualization of the target can help to reduce the margins from CTV to PTV. • MRgRT appears a feasible option in rectal cancer treatment of...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630154/ https://www.ncbi.nlm.nih.gov/pubmed/31341981 http://dx.doi.org/10.1016/j.ctro.2019.04.006 |
_version_ | 1783435239747485696 |
---|---|
author | Chiloiro, Giuditta Boldrini, Luca Meldolesi, Elisa Re, Alessia Cellini, Francesco Cusumano, Davide Corvari, Barbara Mantini, Giovanna Balducci, Mario Valentini, Vincenzo Gambacorta, Maria Antonietta |
author_facet | Chiloiro, Giuditta Boldrini, Luca Meldolesi, Elisa Re, Alessia Cellini, Francesco Cusumano, Davide Corvari, Barbara Mantini, Giovanna Balducci, Mario Valentini, Vincenzo Gambacorta, Maria Antonietta |
author_sort | Chiloiro, Giuditta |
collection | PubMed |
description | • This study represents one of the first reports of online MRgRT. • Integrated Low-field MR provides better anatomical visualization than CBCT or MVCT. • Better visualization of the target can help to reduce the margins from CTV to PTV. • MRgRT appears a feasible option in rectal cancer treatment offering potential benefits. • MRgRT represents a promising technology for rectal cancer management. |
format | Online Article Text |
id | pubmed-6630154 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-66301542019-07-24 MR-guided radiotherapy in rectal cancer: First clinical experience of an innovative technology Chiloiro, Giuditta Boldrini, Luca Meldolesi, Elisa Re, Alessia Cellini, Francesco Cusumano, Davide Corvari, Barbara Mantini, Giovanna Balducci, Mario Valentini, Vincenzo Gambacorta, Maria Antonietta Clin Transl Radiat Oncol Article • This study represents one of the first reports of online MRgRT. • Integrated Low-field MR provides better anatomical visualization than CBCT or MVCT. • Better visualization of the target can help to reduce the margins from CTV to PTV. • MRgRT appears a feasible option in rectal cancer treatment offering potential benefits. • MRgRT represents a promising technology for rectal cancer management. Elsevier 2019-04-12 /pmc/articles/PMC6630154/ /pubmed/31341981 http://dx.doi.org/10.1016/j.ctro.2019.04.006 Text en © 2019 Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Chiloiro, Giuditta Boldrini, Luca Meldolesi, Elisa Re, Alessia Cellini, Francesco Cusumano, Davide Corvari, Barbara Mantini, Giovanna Balducci, Mario Valentini, Vincenzo Gambacorta, Maria Antonietta MR-guided radiotherapy in rectal cancer: First clinical experience of an innovative technology |
title | MR-guided radiotherapy in rectal cancer: First clinical experience of an innovative technology |
title_full | MR-guided radiotherapy in rectal cancer: First clinical experience of an innovative technology |
title_fullStr | MR-guided radiotherapy in rectal cancer: First clinical experience of an innovative technology |
title_full_unstemmed | MR-guided radiotherapy in rectal cancer: First clinical experience of an innovative technology |
title_short | MR-guided radiotherapy in rectal cancer: First clinical experience of an innovative technology |
title_sort | mr-guided radiotherapy in rectal cancer: first clinical experience of an innovative technology |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630154/ https://www.ncbi.nlm.nih.gov/pubmed/31341981 http://dx.doi.org/10.1016/j.ctro.2019.04.006 |
work_keys_str_mv | AT chiloirogiuditta mrguidedradiotherapyinrectalcancerfirstclinicalexperienceofaninnovativetechnology AT boldriniluca mrguidedradiotherapyinrectalcancerfirstclinicalexperienceofaninnovativetechnology AT meldolesielisa mrguidedradiotherapyinrectalcancerfirstclinicalexperienceofaninnovativetechnology AT realessia mrguidedradiotherapyinrectalcancerfirstclinicalexperienceofaninnovativetechnology AT cellinifrancesco mrguidedradiotherapyinrectalcancerfirstclinicalexperienceofaninnovativetechnology AT cusumanodavide mrguidedradiotherapyinrectalcancerfirstclinicalexperienceofaninnovativetechnology AT corvaribarbara mrguidedradiotherapyinrectalcancerfirstclinicalexperienceofaninnovativetechnology AT mantinigiovanna mrguidedradiotherapyinrectalcancerfirstclinicalexperienceofaninnovativetechnology AT balduccimario mrguidedradiotherapyinrectalcancerfirstclinicalexperienceofaninnovativetechnology AT valentinivincenzo mrguidedradiotherapyinrectalcancerfirstclinicalexperienceofaninnovativetechnology AT gambacortamariaantonietta mrguidedradiotherapyinrectalcancerfirstclinicalexperienceofaninnovativetechnology |